Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 1,716† | 1,537† | 1,799† | 1,669† | 1,542† |
| Net profit | -6 | -9 | 117 | 141 | 155† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| ADITI M PANANDIKAR | Executive Director | June 30, 2026 |
| SUNDEEP VASANT BAMBOLKAR | Executive Director | June 30, 2026 |
| ABHIJIT YASHWANT GORE | Independent Director | June 30, 2026 |
| AJAY PRASAN MULGAOKAR | Independent Director | June 30, 2026 |
| SATISH MADHAV SHENOY | Independent Director | June 30, 2026 |
| VASUDHA VASANT KAMAT | Independent Director | June 30, 2026 |
| SURESH GOVIND KARE | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
